191 related articles for article (PubMed ID: 33752428)
1. The efficacy of therapeutic apheresis in patients with refractory neuromyelitis optica spectrum disorders: a single-center retrospective study.
Zhang L; Zhuang Y; Liu X; Xu Q; Zhou L; Zou L; Jiang Y; Tian J; Yao H; Chi H; Qiu X; Yang T; Wang D; Yu Y
Ann Palliat Med; 2021 Mar; 10(3):3105-3114. PubMed ID: 33752428
[TBL] [Abstract][Full Text] [Related]
2. Short-term effect of additional apheresis on visual acuity changes in patients with steroid-resistant optic neuritis in neuromyelitis optica spectrum disorders.
Mori S; Kurimoto T; Ueda K; Nakamura M
Jpn J Ophthalmol; 2018 Jul; 62(4):525-530. PubMed ID: 29802557
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic Plasma Exchange in Neuromyelitis Optica Spectrum Disorders and Related Disorders in Resource-Limited Settings: Outcomes in a Multiethnic Single-Center Population.
Ong ZM; Schee JP; Viswanathan S
Ther Apher Dial; 2020 Jun; 24(3):312-323. PubMed ID: 31654607
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic plasma exchange for optic neuritis attacks in patients with neuromyelitis optica spectrum disorders.
Gonzalez C; Vargas D; Contreras K; Garcia P; Rodriguez P; Zarco L; Navas C
Ther Apher Dial; 2022 Dec; 26(6):1274-1280. PubMed ID: 35353437
[TBL] [Abstract][Full Text] [Related]
5. Sequential intermittent therapeutic plasma exchange: A possible induction and maintenance therapy in the management of adult patients with neuromyelitis optica spectrum disorder.
Viswanathan S; Schee JP; Omar MA; Hiew FL
Ther Apher Dial; 2021 Aug; 25(4):513-532. PubMed ID: 33029928
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic plasma exchange vs conventional treatment with intravenous high dose steroid for neuromyelitis optica spectrum disorders (NMOSD): a systematic review and meta-analysis.
Siritho S; Nopsopon T; Pongpirul K
J Neurol; 2021 Dec; 268(12):4549-4562. PubMed ID: 33037886
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Plasma Exchange in Neuromyelitis Optica Spectrum Disorders-Experience from Tertiary Care Center in North India.
Hans R; Prakash S; Sharma RR; Sankhyan N; Takkar A; Goyal M; Saikia B; Lal V; Marwaha N
Neurol India; 2022; 70(2):710-713. PubMed ID: 35532644
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic plasma exchange for neuromyelitis optica spectrum disorder: A multicenter retrospective study by the ASFA neurologic diseases subcommittee.
Ipe TS; Raval JS; Fernando LP; Gokhale A; Jacquot C; Johnson AD; Kim HC; Monis GF; Mo YD; Morgan SM; Pagano MB; Pham HP; Sanford K; Schmidt AE; Schwartz J; Waldman A; Webb J; Winters JL; Wu Y; Yamada C; Wong ECC
J Clin Apher; 2020 Jan; 35(1):25-32. PubMed ID: 31705563
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of plasma exchange for the treatment of optic neuritis in neuromyelitis optica spectrum disorders: A protocol for systematic review and meta-analysis.
Han M; Chen Y; Nong L; Liu Z; Hao L; Wang Z
Medicine (Baltimore); 2020 Jul; 99(28):e21067. PubMed ID: 32664124
[TBL] [Abstract][Full Text] [Related]
10. [Progress in the treatment of neuromyelitis optica spectrum disorders related optic neuritis].
Song HL; Xu QG; Wei SH
Zhonghua Yan Ke Za Zhi; 2020 Jul; 56(7):539-543. PubMed ID: 32842338
[TBL] [Abstract][Full Text] [Related]
11. Prognostic indicators of improvement with therapeutic plasma exchange in pediatric demyelination.
Savransky A; Rubstein A; Rios MH; Vergel SL; Velasquez MC; Sierra SP; Marcarian G; Alba R; Pugliese AM; Tenembaum S
Neurology; 2019 Nov; 93(22):e2065-e2073. PubMed ID: 31645471
[TBL] [Abstract][Full Text] [Related]
12. Plasma exchange: an effective add-on treatment of optic neuritis in neuromyelitis optica spectrum disorders.
Song W; Qu Y; Huang X
Int Ophthalmol; 2019 Nov; 39(11):2477-2483. PubMed ID: 30825049
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes and predictive factors related to good outcomes in plasma exchange in severe attack of NMOSD and long extensive transverse myelitis: Case series and review of the literature.
Aungsumart S; Apiwattanakul M
Mult Scler Relat Disord; 2017 Apr; 13():93-97. PubMed ID: 28427710
[TBL] [Abstract][Full Text] [Related]
14. Effect of plasma exchange in neuromyelitis optica spectrum disorder: A systematic review and meta-analysis.
Kosiyakul P; Songwisit S; Ungprasert P; Siritho S; Prayoonwiwat N; Jitprapaikulsan J
Ann Clin Transl Neurol; 2020 Nov; 7(11):2094-2102. PubMed ID: 32956562
[TBL] [Abstract][Full Text] [Related]
15. Optic neuritis at disease onset predicts poor visual outcome in neuromyelitis optica spectrum disorders.
Amaral JM; Talim N; Kleinpaul R; Lana-Peixoto MA;
Mult Scler Relat Disord; 2020 Jun; 41():102045. PubMed ID: 32179485
[TBL] [Abstract][Full Text] [Related]
16. Immunoadsorption as maintenance therapy for refractory neuromyelitis optica spectrum disorder.
Heigl F; Hettich R; Fassbender C; Klingel R; Mauch E; Durner J; Kern R; Kleiter I
Ther Adv Neurol Disord; 2023; 16():17562864221150314. PubMed ID: 36762319
[TBL] [Abstract][Full Text] [Related]
17. Plasma exchange for acute optic neuritis in neuromyelitis optica or neuromyelitis optica spectrum disorder: a systematic review.
Naphattalung Y; Chuenkongkaew WL; Chirapapaisan N; Laowanapiban P; Sawangkul S
Ann Med; 2023 Dec; 55(1):2227422. PubMed ID: 37387119
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of treatments in Neuromyelitis optica to modify the course of disease in adult patients. Systematic review of literature.
Velasco M; Zarco LA; Agudelo-Arrieta M; Torres-Camacho I; Garcia-Cifuentes E; Muñoz O
Mult Scler Relat Disord; 2021 May; 50():102869. PubMed ID: 33711580
[TBL] [Abstract][Full Text] [Related]
19. The efficacy and safety of mycophenolate mofetil in Thai neuromyelitis optica spectrum disorder patients.
Pathomrattanapiban C; Tisavipat N; Jitprapaikulsan J; Prayoonwiwat N; Rattanathamsakul N; Siritho S
Mult Scler Relat Disord; 2022 Jul; 63():103882. PubMed ID: 35598463
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of modified reduced-dose rituximab in Chinese patients with neuromyelitis optica spectrum disorder: A retrospective cohort study.
Cao S; Yu H; Tian J; Li Y; Shen Y; Ji X; Wang X; Zhou X; Gu Y; Zhu F; Duan X; Xiao X; Fang Q; Chen X; Xue Q
J Neurol Sci; 2021 Oct; 429():117616. PubMed ID: 34450520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
